Clinical Services
The L-asparaginase assay is a laboratory developed test (LDT) to determine the enzyme activity of L-asparaginase in patients who have been treated with Oncaspar®, Asparlas®. Erwinaze®, or Rylaze®. This assay has been validated and is performed in our CLIA certified laboratory to monitor the asparaginase activity level during a patient’s treatment. Since 2016, we have performed more than 28000 individual assays on patient samples, and we currently service more than 250 institutions worldwide including hospitals and clinics in Canada, Switzerland, Hong Kong, Singapore, and the United Arab Emirates. Our assay is also used to support on-going pediatric and adult clinical trials, and just recently our assay has been used in support of pre-clinical veterinary trials.
At our laboratory, we provide comprehensive blood chemistry testing tailored specifically for assisted living and nursing homes. Our fast turnaround times ensure that critical care needs are met promptly. We pride ourselves on delivering professional and compassionate blood draw services, prioritizing the and well-being of your residents. Our lab services can be used by any physician practice needing routine blood chemistry testing. Trust NEXT to support your healthcare facility with reliable and efficient testing.
Urine Testing
NEXT uses a revolutionary new technology for rapid UTI detection. This test can detect an infection in 3 hours.
Positive samples can be automatically submitted to MIC,/antibiotic sensitivity and resistance testing using our Vitek testing system. Next also includes Candida PCR testing.
NEXT also provides comprehensive Urinalysis testing for routine screening or if you the patient has symptoms of an infection, diabetes, or kidney or liver issues.
NEXT offers a comprehensive range of respiratory diagnostics designed specifically for healthcare providers. Understanding that many respiratory infections exhibit similar symptoms, our testing options aid accurately identifying the underlying pathogens. With our reliable and efficient diagnostic tools, you can enhance ability to diagnose and treat respiratory infections effectively. Trust NEXT for precision in respiratory testing.
NEXT Molecular Analytics offers advanced genetic testing that empowers physicians to tailor medication treatments based on each patient's unique genetic makeup. By understanding how individuals metabolize medications differently, we help ensure that patients receive the most effective and personalized care possible. Trust us to provide the insights needed for better treatment outcomes.
NEXT Molecular accepts most major insurance plans, including the following:
-Original Medicare
-Medicare Advantage/Dual Advantage
-Commercial PPO/POS
-Tricare
-Virginia State Medicaid Fee-For-Service (FFS)
NEXT cannot accept orders with HMO, EPO or Medicaid Managed Care (MCO) policies.
CONTACT NEXT info@nextmolecular.com
toll free 844-812-7415
for more information, to request a sample collection kit and sample requisition form, or any other relevant documents needed for testing.